Trademark: 85637385
Word
C CELGENE
Status
Dead
Status Code
710
Status Date
Friday, June 9, 2023
Serial Number
85637385
Registration Number
4250217
Registration Date
Tuesday, November 27, 2012
Mark Type
3000
Filing Date
Tuesday, May 29, 2012
Published for Opposition
Tuesday, September 11, 2012
Cancellation Date
Friday, June 9, 2023

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
41 educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; education services, namely, providing mentoring, tutoring, classes, seminars, and workshops in the fields of highlighting the advancements made in cancer treatments and discussing the importance of continuing research to develop innovative new treatments
5 pharmaceutical preparations for use in the treatment of immunological, inflammatory and neurological disorders
35 Administration of patient reimbursement programs; administering pharmacy reimbursement programs and services
44 providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer
42 Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; providing an interactive web site that enables users to enter, access, track, monitor and generate health and medical information and reports; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
The mark consists of a blue design in the shape of a "c" with the words "CELGENE" in blue.
C CELL GENE
The color(s) blue is/are claimed as a feature of the mark.

Trademark Events
Jun 9, 2023
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Nov 27, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 10, 2020
Notice Of Suit
Apr 20, 2020
Notice Of Suit
Jan 3, 2018
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 3, 2018
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 20, 2017
Case Assigned To Post Registration Paralegal
Nov 27, 2017
Teas Section 8 & 15 Received
Nov 27, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 28, 2015
Teas Change Of Correspondence Received
Nov 27, 2012
Registered-Principal Register
Sep 11, 2012
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2012
Published For Opposition
Aug 22, 2012
Notification Of Notice Of Publication E-Mailed
Aug 7, 2012
Law Office Publication Review Completed
Aug 7, 2012
Assigned To Lie
Jul 23, 2012
Approved For Pub - Principal Register
Jul 23, 2012
Examiner's Amendment Entered
Jul 23, 2012
Notification Of Examiners Amendment E-Mailed
Jul 23, 2012
Examiners Amendment E-Mailed
Jul 23, 2012
Examiners Amendment -Written
Jul 23, 2012
Assigned To Examiner
Jun 6, 2012
Notice Of Design Search Code Mailed
Jun 5, 2012
New Application Office Supplied Data Entered
Jun 1, 2012
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24